Investigation of the Effect of Nomophobia on Musculoskeletal System and Sleep
1 other identifier
observational
200
1 country
1
Brief Summary
The aim of this study; Investigation of the effects on the musculoskeletal system and sleep by determining the nomophobia levels of individuals between the ages of 18-25.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 6, 2023
CompletedDecember 7, 2023
December 1, 2023
1 month
August 17, 2023
December 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Nomophobia Scale
The Nomophobia Scale was itemized according to a 7-point Likert type. Out of 20 items in total consists of. The scale has four sub-dimensions: Lack of Access to Information (4 items), Losing Connection (5 items), Inability to Communicate (6 items), and Comfort Inability to feel (5 items).
2 days
Cornell Musculoskeletal Disorder Questionnaire
The questionnaire was conducted in 11 body regions (neck, right and left shoulder, upper arm, forearm and wrist, back and waist region) includes questions about the frequency of musculoskeletal disorders (pain/pain/discomfort), the severity of these disorders, and whether they interfere with work.
2 days
Smart phone Addiction Scale
It is a scale developed to measure the risk of smart phone addiction, consisting of 10 items and evaluated with a six-point Likert scale. Scale items were scored from 1 to 6. Scale scores range from 10 to 60. As the score obtained from the test increases, it is considered that the risk for addiction increases.
2 days
Pittsburgh Sleep Quality Index
It is a 19-item self-report scale that evaluates sleep quality and impairment over the past month. It consists of 24 questions, 19 questions are self-report questions, 5 questions are questions to be answered by the spouse or roommate. The 18 scored questions of the scale consist of 7 components. Subjective Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disorder, Sleeping Drug Use and Daytime Dysfunction. Each component is evaluated over 0-3 points. The total score of the 7 components gives the scale total score. The total score ranges from 0 to 21. A total score greater than 5 indicates "poor sleep quality".
2 days
International Physical Activity Questionnaire Short Form
The questionnaire consisting of seven questions including the activities of the last seven days was prepared by the individuals themselves. self-applicable and provides information about the time people spend in moderate to vigorous activities
2 days
McGill Melzack Pain Questionnaire
Pain Questionnaire consists of four parts. With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of livable pain for the individual are determined.
2 days
Study Arms (4)
1.Group
Nomophobia Level:none
2.Group
Nomophobia Level: mild
3.Group
Nomophobia Level: medium
4.Group
Nomophobia Level: extreme
Interventions
The scales and forms used are respectively: 1. Demographic Information Form 2. Nomophobia Scale 3. Cornell Musculoskeletal Disorder Questionnaire 4. Smart phone Addiction Scale 5. Pittsburgh Sleep Quality Index 6. International Physical Activity Survey 7. McGill Melzack Pain Questionnaire
Eligibility Criteria
people with whom we were able to create the survey and who met the inclusion criteria
You may qualify if:
- To have accepted the voluntary consent form that requires participation in the survey study.
- Being a smart phone user
You may not qualify if:
- Not accepting the volunteer consent form
- Having undergone previous surgery
- Being on antidepressants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uskudar Üniversity
Istanbul, Turkey (Türkiye)
Related Publications (5)
Bhattacharya S, Bashar MA, Srivastava A, Singh A. NOMOPHOBIA: NO MObile PHone PhoBIA. J Family Med Prim Care. 2019 Apr;8(4):1297-1300. doi: 10.4103/jfmpc.jfmpc_71_19.
PMID: 31143710BACKGROUNDKuscu TD, Gumustas F, Rodopman Arman A, Goksu M. The relationship between nomophobia and psychiatric symptoms in adolescents. Int J Psychiatry Clin Pract. 2021 Mar;25(1):56-61. doi: 10.1080/13651501.2020.1819334. Epub 2020 Sep 17.
PMID: 32940094BACKGROUNDNotara V, Vagka E, Gnardellis C, Lagiou A. The Emerging Phenomenon of Nomophobia in Young Adults: A Systematic Review Study. Addict Health. 2021 Apr;13(2):120-136. doi: 10.22122/ahj.v13i2.309.
PMID: 34703533BACKGROUNDRahme C, Hallit R, Akel M, Chalhoub C, Hachem M, Hallit S, Obeid S. Nomophobia and temperaments in Lebanon: Results of a national study. Perspect Psychiatr Care. 2022 Oct;58(4):1607-1612. doi: 10.1111/ppc.12968. Epub 2021 Nov 6.
PMID: 34741546BACKGROUNDJahrami HA, Fekih-Romdhane F, Saif ZQ, Alhaj OA, AlRasheed MM, Pandi-Perumal SR, BaHammam AS, Vitiello MV. Sleep dissatisfaction is a potential marker for nomophobia in adults. Sleep Med. 2022 Oct;98:152-157. doi: 10.1016/j.sleep.2022.07.001. Epub 2022 Jul 11.
PMID: 35868112BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Melek ÖZCAN
Uskudar University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof. Dr.
Study Record Dates
First Submitted
August 17, 2023
First Posted
August 23, 2023
Study Start
September 1, 2023
Primary Completion
October 2, 2023
Study Completion
December 6, 2023
Last Updated
December 7, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share